Urgent call for affordable diabetes treatment: Senate hearing highlights pharmaceutical markup crisis
Pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi have been challenged by Doctors Without Borders to take ...
The Lancet3h
Jens Juul Holst: physician-scientist and co-discoverer of GLP-1
In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...
ConsumerAffairs4h
Why are prescription drugs so much more expensive in the US?
noted that Novo Nordisk’s weight loss drug Ozempic sells for $969 ... In the case of Ozempic and similar GLP-1 drugs, the ...
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
A weight loss drug developer's stock soars after a $198 million IPO
Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...
An oral weight loss pill has just passed early trials with promising results—here's how it works
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
Hosted on MSN13h
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
The drug and biotech sector has outperformed the broader equity market this year, backed by the launch of promising new ...
Weight loss injections boom
An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...
FiercePharma13h
Novo Nordisk scolded by UK drug marketing watchdog over sponsorship of weight loss services
Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...
Columbus woman took Ozempic, now she can't eat without vomiting. So she's suing.
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
BioSpace15h
Novo’s Ozempic Potentially Linked to Lower Opioid Overdose Risk in Diabetics
A retrospective cohort study of more than 33,000 patients with type 2 diabetes showed that Novo Nordisk’s GLP-1 may lower the risk of opioid overdose by 42% to up to 68%.
She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.